Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hydroxyapatite crystal lattice of tooth enamel refers to the highly organized, tightly packed network of hydroxyapatite (calcium phosphate) crystals forming the primary mineral structure of human dental enamel. This lattice makes up about 95–97% of tooth enamel by weight and is responsible for its exceptional hardness, resilience, and ability to protect the underlying tooth tissue from mechanical and chemical insults[1][2][3][5][6]. In enamel, hydroxyapatite is arranged into rods (or prisms) and interrod regions, with unique orientations contributing to enamel’s strength and resistance to fracture[1][3][6]. Though enamel hydroxyapatite is the body’s hardest tissue, it is susceptible to demineralization by acids, and cannot regenerate naturally if lost. Fluoride and mineralizing treatments can remineralize damaged areas but cannot restore lost lattice structure[4][1].
Remineralization: provides calcium and phosphate ions to repair hydroxyapatite lattice; Fluoride incorporation: converts hydroxyapatite to the more acid-resistant fluorapatite; Inhibition of demineralization: slows/enhances resistance to acid-induced breakdown
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hydroxyapatite crystal lattice of tooth enamel.